GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Forward Dividend Yield %

Bharat Immunologicals & Biologicals (BOM:524663) Forward Dividend Yield % : 0.00% (As of May. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Forward Dividend Yield %?

As of today (2024-05-28), the Forward Annual Dividend Yield of Bharat Immunologicals & Biologicals is 0.00%.

As of today (2024-05-28), the Trailing Annual Dividend Yield of Bharat Immunologicals & Biologicals is 0.00%.

BOM:524663's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.63
* Ranked among companies with meaningful Forward Dividend Yield % only.

Bharat Immunologicals & Biologicals's Dividends per Share for the three months ended in Sep. 2023 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Bharat Immunologicals & Biologicals's Forward Dividend Yield %

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Forward Dividend Yield % falls into.



Bharat Immunologicals & Biologicals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Bharat Immunologicals & Biologicals  (BOM:524663) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Bharat Immunologicals & Biologicals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines